Loading
Yifan Pharmaceutical Co., Ltd. Stock: price and insider trades · China
亿帆医药
No insider purchase over the last 90 days. The latest, by 李锡明, was filed 08 Feb 2024.
Yifan Pharmaceutical Co., Ltd.: what insiders have been doing
Yifan Pharmaceutical Co., Ltd. has a thin disclosure history in our data (latest filing: 8 February 2024). New filings will appear here as soon as they are published. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€39,469
1 ops. · all time
Sell Volume
n/a
n/a
Since the insiders bought
- -5.3%Entry CN¥11.60 · Close at T+365 CN¥10.99
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 14,507 of 24,166 companies
45.5
score / 100
Value40
Quality51
FCF yld-0.9%
Earn yld3.5%
EV/EBITDA16.7x
ROE3.2%
Gross mgn47%
Net mgn7.8%
Debt/EBITDA2.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥9.42
Analyst consensus
1 analystsCN¥13.00Target CN¥13.00(+38%)CN¥13.00
Income statement
RevenueCN¥5.1B
Gross profitCN¥2.4B47% margin
EBITDACN¥825.5M16% margin
Net incomeCN¥402M6.1% margin
Valuation
PER (trailing)37.7x
P/Book1.1x
Beta0.47
Balance sheet & cash
Market capCN¥11.5B
Total debtCN¥2.4B
Free Cash Flow-CN¥100.9M
Debt / Equity28%
Profitability & ownership
ROE3.2%
ROA1.7%
% insiders43.2%
% institutions5.4%
Last declaration on 8 February 2024
About Yifan Pharmaceutical Co., Ltd.
亿帆医药 is a company specializing in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and manufacturing of innovative drugs.
